₫67000.00
+
₫700.00 (1.06%)
End-of-day quote: 05/16/2024
HOSE:IMP
Imexpharm Annual Report
| Year | Year | 2023 | ||
|---|---|---|---|---|
| Rev. | Revenue |
|
₫1.99T | |
| GM % | Gross Margin % |
|
49.35% | |
| OM | Operating Margin |
|
19.11% | |
| EPS | Earnings Per Share |
|
₫0.00 | ₫3.64k |
| Div. | Dividends |
|
₫1.43k | |
| PR % | Payout Ratio % |
|
39.28% | |
| Sha. | Shares |
|
70m | |
| OCF | Operating Cash Flow |
|
₫-39534.84M | |
| FCF | Free Cash Flow |
|
₫-236873.38M | |
| FCFS | Free Cash Flow Per Share |
|
₫-1472.25 |
